Navigation Links
In Some Insomnia Patients, Brain Just Won't Shut Down
Date:6/9/2009

Abnormal levels of a neurochemical are linked to sleep disorder, study finds

TUESDAY, June 9 (HealthDay News) -- Adults with primary insomnia have a neurochemical abnormality that makes it difficult to "shut down" the mind at night for sleep, new research has found.

Researchers measured the levels of gamma-aminobutyric acid (GABA) in 16 adult men and women with primary insomnia and 16 men and women deemed normal sleepers.

Primary insomnia is difficulty falling sleep or staying asleep at night for over a period of at least one month, according to the American Academy of Sleep Medicine. Unlike most cases of insomnia, primary insomnia can't be attributed to a psychiatric, medical or environmental cause.

The new study found that people who had suffered from primary insomnia for more than six months had 30 percent lower levels of GABA.

GABA, the most common inhibitory transmitter in the brain, slows overall activity in many brain areas.

The research was to be presented June 9 at the annual meeting of the Associated Professional Sleep Societies, in Seattle.

The findings suggest that primary insomnia is the result of a neurobiological state of hyperarousal, and that this state remains throughout the day and night, affecting the individual's mind and body, according to a news release from the American Academy of Sleep Medicine. About one-quarter of people with insomnia have this type, the Academy stated.

Understanding that primary insomnia is associated with a specific neurochemical deficiency helps validate the often-misunderstood complaint of insomnia, explained lead study author Dr. John Winkelman of Brigham and Women's Hospital at Harvard Medical School in Boston.

"Recognition that insomnia has manifestations in the brain may increase the legitimacy of those who have insomnia and report substantial daytime consequences," Winkelman said. "Insomnia is not just a phenomenon observed at night, but has daytime consequences for energy, concentration and mood."

More information

The U.S. National Institutes of Health has more on primary insomnia.



-- Jennifer Thomas



SOURCE: American Academy of Sleep Medicine, news release, June 9, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007
2. Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness
3. Insomniac Fish May Help Sleepless People
4. Journal Sleep: A short-term dose of zolpidem is an effective treatment for insomnia
5. Ambien CR(R) (zolpidem tartrate extended-release) tablets CIV Improved Chronic Insomnia in Patients with Co-Morbid Generalized Anxiety Disorder
6. Insomnia patients often denied sleep treatment when they have mental health conditions
7. Adolescents with chronic insomnia report twofold to fivefold increase in personal problems
8. Persistent Insomnia Leads to Depression in Young Adults
9. An Eye-Opening Look at Insomnia
10. A self-help program delivered online can improve insomnia in adults
11. Insomnia in parents can result in sleep problems, suicidal behavior among their offspring
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
In Some Insomnia Patients, Brain Just Won't Shut Down
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... choose a modern procedure that achieves results in a fraction of the time ... Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary treatment with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of America ... a reputable physician in their area, announces the launch of a new and proprietary ... who are looking for reputable physicians to help them with back or neck pain ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... addition of predictive analytics to its patient care management module. Using this new ... before a patient has been initiated on continuous positive airway pressure (CPAP), oral, ...
(Date:4/25/2017)... ... 2017 , ... Vetoquinol USA® , a world-class developer ... of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. ... level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the ... CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet in ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... PARIS , April 20, 2017 ... EyeCET platform, the first non-viral gene expression technology that ... in the eye to address a wide range of ... UK Medicines and Healthcare products Regulatory Agency (MHRA) to ... ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
Breaking Medicine Technology: